FIELD: medicine.
SUBSTANCE: present invention relates to a compound, which is used as potassium channel openers, namely to (S)-3-(3,4-difluorophenyl)-1-(5-chloro-2,3-dihydro-1H-indene-1-yl)-1-methylurea. A pharmaceutical composition and a drug are also proposed, containing the effective amount of the above-mentioned compound.
EFFECT: proposed compound is active as potassium channel openers, and it can be used for the prevention or treatment of a disorder related to aberrant activity of potassium channels.
5 cl, 1 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NEW COMPOUNDS USED AS POTASSIUM CHANNEL OPENERS | 2018 |
|
RU2779131C2 |
| NON-AQUEOUS GEL COMPOSITION | 2021 |
|
RU2822601C1 |
| SUBSTITUTED NICOTINAMIDES AS KCNQ2-3 MODULATORS | 2010 |
|
RU2529904C2 |
| 2-OXA-5-AZABICYCLO[2.2.1]HEPTANE-3-YL DERIVATIVES | 2015 |
|
RU2697651C2 |
| APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
| METHOD FOR PREDICTING THE THERAPEUTIC EFFECT OF AN LSD 1INHIBITOR BASED ON THE INSM1 EXPRESSION | 2018 |
|
RU2789449C2 |
| DERIVANTS OF BICYCLO[2, 2, 1] HEPT-7-YLAMINE AND THEIR APPLICATIONS | 2006 |
|
RU2442771C2 |
| BORONIC ACID DERIVATIVES | 2018 |
|
RU2793315C2 |
| DERIVATIVES OF 2- PYRROLIDINE-2-YL-[1, 3, 4]OXADIAZOLE AND THEIR USE AS ANTIDEPRESSANT AGENTS | 2003 |
|
RU2324694C2 |
| ANTITUMOR EFFECT ENHANCER USING NEW BIPHENYL COMPOUND | 2018 |
|
RU2765153C2 |
